Bioterrorism and patent rights: "compulsory licensure" and the case of cipro

American Journal of Bioethics

Volumn 2, Issue 3, 2002, Pages 29-39

  Resnik, David B ^a   De Ville, Kenneth A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Anthrax; Bioterrorism; Cipro; Patents; Pharmaceutical companies

Indexed keywords

CIPROFLOXACIN; DRUG;

ANALYTICAL APPROACH; ANTHRAX; ARTICLE; BAYER INC.; BIOLOGICAL WARFARE; COMPENSATION; DRUG INDUSTRY; ECONOMICS; ETHICAL THEORY; ETHICS; FINANCIAL MANAGEMENT; FREEDOM; GOVERNMENT; HEALTH CARE AND PUBLIC HEALTH; HUMAN; INTERNATIONAL COOPERATION; LEGAL APPROACH; LEGAL ASPECT; LICENSING; ORGANIZATION AND MANAGEMENT; PATENT; POLICY; PUBLIC HEALTH; SOCIAL JUSTICE; TIME; UNITED STATES; WAR AND HUMAN RIGHTS ABUSES;

ANALYTICAL APPROACH; BAYER INC.; HEALTH CARE AND PUBLIC HEALTH; LEGAL APPROACH; WAR AND HUMAN RIGHTS ABUSES;

ANTHRAX; BIOTERRORISM; CIPROFLOXACIN; COMPENSATION AND REDRESS; DRUG INDUSTRY; ETHICAL ANALYSIS; ETHICAL THEORY; FEDERAL GOVERNMENT; FREEDOM; HUMANS; INTELLECTUAL PROPERTY; INTERNATIONALITY; LICENSURE; PATENTS; PHARMACEUTICAL PREPARATIONS; PRIVATE SECTOR; PUBLIC HEALTH; PUBLIC POLICY; PUBLIC SECTOR; RESEARCH SUPPORT; SOCIAL JUSTICE; TIME FACTORS; UNITED STATES;

EID: 0036594080     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651602760250084     Document Type: Article

References (24)

1. Andrews, E. 2001. Bayer reaches deal on Cipro to protect patent in Canada. The New York Times, 23 October, A1
2. Anonymous. 2001. Big pharma’s payoff. The Nation 273(15):3.
3. Bennett P. 2001. Defending against anthrax: U.S. patent implications and safeguarding public health. The Metropolitan Corporate Counsel, November, 13.
4. Blumenthal, D., et al. 1997. Withholding research results in academic life sciences: Evidence from a national survey. JAMA 277:1224-28.
5. Bodenheimer, T. 2000. Uneasy alliance: Clinical investigators and the pharmaceutical industry. The New England Journal of Medicine 342:1539-43.
6. Bradsher, K. 2001. Bayer halves price for Cipro, but rivals offer drugs free. The New York Times, 25 October, A1
7. Business: Patent remedies; Compulsory licensing. 2001. The Economist 361(8245):100.
8. Enserink M. 2001. Researchers question obsession with Cipro. Science 294:759-761.
9. Federal Acquisition Regulations. 2001. Authorization and consent. FAR 52.227-1-FAR 52.227-3. Washington: GPO.
10. Fuhrmans, V., and R. Winslow. 2001. Bayer works to meet soaring Cipro demand. The Wall Street Journal, 22 October, A1.
11. Inglesby, T., D. Henderson, J. Bartlett et al. 1999. Anthrax as a biological weapon. JAMA 281:1735-45.
12. Janicke, P. 2001. Current state of U.S. patent law regarding infringement of drug patents by the government. Health Law Perspectives, 7 December. Available from: http://www.law.uh.edu/healthlawperspectives/Food/011207Current.html.
13. Kionka, E. 1999. Torts. St. Paul: West Group.
14. Miller, A., and M. Davis. 2000. Intellectual property. St. Paul: West Group.
15. Nader, R., and J. Love. 2001. Letter to Tommy G. Thompson, Secretary of Health and Human Services. The Washington Post, 18 October.
16. Nowak, J. E., and R. D. Rotunda. 1995. Constitutional law, Fifth Ed. St. Paul: West Publishing Co.
17. Paterson, L. 2001. U.S. patent reappraisal poses long-term dangers. The London Times, 29 October. Available from: http://www.thetimes.co.uk/article/0,,37-2001373569,00.html.
18. Pharmaceutical Research and Manufacturing Association (PHRMA). 2000. The pharmaceutical industry’s r & d investment. Washington: PHRMA.
19. Resnik, D. 2001a. DNA patents and scientific discovery and innovation: Assessing benefits and risks. Science and Engineering Ethics 7:29-62.
20. Resnik, D. 2001b. Developing drugs for the developing world: An economic, legal, moral, and political dilemma. Developing World Bioethics 1:11-32.
21. Stapleton, S. 2001. Doctors, health system facing new challenges from anthrax. Amednews.com, 5 November. Available from: http://www.ama-assn.org/sci-pubs/amnews.
22. Vedantam, S. 2001. Older, far cheaper medications may work as well, experts say. The Washington Post, 17 October, A1.
23. Working Group on Research Tools. 1998. Report of the National Institutes of Health (NIH) Working Group on Research Tools, June 4, 1998. Available from: http://www.nih.gov/news/research tools/.
24. World Trade Organization (WTO). 1996. Trade-related aspects of intellectual property (TRIPS) agreement. Geneva: WTO.